Stephen L. Sabba, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 1,850 shares at $137.25 ($254K) on 2017-12-20, disclosed to the SEC on 2017-12-21.
Open-market sale of $254k LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $137.25 | 925 | $127K | 50.0% |
| 2 | $137.25 | 925 | $127K | 50.0% |
| Total | $137.25 avg | 1,850 | $254K | 100% |
| Filing → |
| LGND | SELL | 2026-03-05 | $410K | — | Filing → |
| LGND | SELL | 2024-03-07 | $281K | — | Filing → |
| LGND | SELL | 2023-05-12 | $988K | — | Filing → |